Abstract: Somatoform disorders(SFDs) are symptoms of mind and body comorbidities closely related to mental psychology. It is the earliest discovery in psychosomatics. Generally, it is impossible to ascertain the positive result through physical examination and laboratory tests fot this type of patient and as a diagnosis basis for SDFs. Trace the origin of the bygone, somatoform disorders was first described by Briquet as the symptom group of these diseases and they were later included in the scope of hysteria by Freus and Breuer. It was not until 1980 that DSM-Ⅲ first classified SFDs as separate category and tied it with anxiety disorders. The dominant symptom of SDFs is concerned about the long-term dominance of the physical symptoms. The first place of patients’ initial visited was the specialist clinic. Due to the high rate of patients return, as long as they are treated by a specialist once or twice and contact psychiatric clinic, they will be preliminary identified as SFDs. In this paper, the neuroimaging imaging of five SFDs, including somatization disorder, hypochondria, conversion disorder, chronic fatigue syndrome and body dysmorphic disorder, was analyzed from the perspective of functional imaging. The technique detected that some anisotropy values were abnormal and the glucose metabolism rate was lower than the general normal value in the dorsolateral prefrontal cortex, ventrolateral prefrontal cortex, frontal pole, anterior cingulate cortex, inferior parietal lobule and hippocampal gyrus of patients. When testing the working memory ability of patients with SFDs using the mental disorder magnetic resonance imaging test, it was found that once the task was enhanced to the 2-back level, the declining tendency of the blood oxygen level dependence of patients began to slow down. Finally, the mechanism of SFDs pathogenesis was demonstrated from the following aspects of the monoamine hypothesis of neurobiochemistry, the phenomenon of dopaminergic hyperactivity, and the influence of substance P and opioid neuromodulators.